Loading...
•
Dec 31, 2020
Enovis Q4 2020 Earnings Report
Colfax reported Q4 2020 results, achieving $0.29 EPS and $0.51 adjusted EPS.
Key Takeaways
Colfax Corporation announced strong Q4 2020 results with net sales of $828 million and adjusted EPS of $0.51. The company also completed the acquisition of two medical technology businesses and provided a positive 2021 growth outlook.
Reported $0.29 EPS from continuing operations and achieved $0.51 of adjusted EPS.
Net sales increased to $828 million, a 3% sequential increase from Q3 2020.
Generated operating cash flow of $129 million and free cash flow of $96 million.
Announced 2021 outlook with expectations for significant revenue, profit, and cash flow growth.
Enovis
Enovis
Forward Guidance
Colfax expects significant growth in sales, earnings and cash flow in 2021.
Positive Outlook
- Revenue is expected to grow 15-18% from the prior year.
- Adjusted earnings to grow at least 44% to $2.00 to $2.15 per diluted share.
- Projecting free cash flow of $250 million or more.
- Expects adjusted earnings of $0.35 to $0.40 per diluted share for Q1 2021.
- Sequentially improving throughout the year due to seasonality and expected recovery in customer demand.